Verkazia is a Ophthalmic; Topical Emulsion in the Human Prescription Drug category. It is labeled and distributed by Santen Incorporated. The primary component is Cyclosporine.
| Product ID | 65086-001_c795cd2f-89db-78e3-e053-2a95a90a9422 |
| NDC | 65086-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Verkazia |
| Generic Name | Cyclosporine |
| Dosage Form | Emulsion |
| Route of Administration | OPHTHALMIC; TOPICAL |
| Marketing Start Date | 2022-02-01 |
| Marketing Category | NDA / |
| Application Number | NDA214965 |
| Labeler Name | Santen Incorporated |
| Substance Name | CYCLOSPORINE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Calcineurin Inhibitor Immunosuppressant [EPC], Calcineurin Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2022-02-01 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0074-3108 | Gengraf | Cyclosporine |
| 0074-3109 | Gengraf | Cyclosporine |
| 0074-7269 | Gengraf | Cyclosporine |
| 0078-0246 | Neoral | cyclosporine |
| 0078-0248 | Neoral | cyclosporine |
| 0023-9163 | RESTASIS | cyclosporine |
| 0023-5301 | Restasis MultiDose | cyclosporine |
| 0078-0109 | Sandimmune | cyclosporine |
| 0078-0110 | Sandimmune | cyclosporine |
| 0078-0240 | Sandimmune | cyclosporine |
| 0078-0241 | Sandimmune | cyclosporine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VERKAZIA 90001921 not registered Live/Pending |
Santen S.A.S 2020-06-15 |